Comparison among patients≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents.

[1]  S. Silber,et al.  The influence of age on clinical outcomes in patients treated with the resolute zotarolimus‐eluting stent , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  J. Wójcik,et al.  6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial. , 2015, Journal of the American College of Cardiology.

[3]  Antonio Colombo,et al.  Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. , 2014, Journal of the American College of Cardiology.

[4]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  N. Curzen,et al.  A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly). , 2014 .

[6]  A. Kastrati,et al.  Incidence and prognostic value of bleeding after percutaneous coronary intervention in patients older than 75 years of age , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  J. Wójcik,et al.  Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial , 2014 .

[8]  W. Wijns,et al.  Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease. , 2013, Archives of cardiovascular diseases.

[9]  G. Stone,et al.  Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. , 2013, Journal of the American College of Cardiology.

[10]  P. Serruys,et al.  Short- and long-term outcomes in octogenarians undergoing percutaneous coronary intervention with stenting. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[12]  G. Stone,et al.  Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis , 2012, The Lancet.

[13]  K. Anstrom,et al.  Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States. , 2012, Journal of the American College of Cardiology.

[14]  W. Wijns,et al.  Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting. , 2011, American heart journal.

[15]  Michael P. Thomas,et al.  Outcome of Contemporary Percutaneous Coronary Intervention in the Elderly and the Very Elderly: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium , 2011, Clinical cardiology.

[16]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[17]  P. Serruys,et al.  Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries). , 2010, The American journal of cardiology.

[18]  J. Pell,et al.  Percutaneous Coronary Intervention in the Elderly: Changes in Case-Mix and Periprocedural Outcomes in 31 758 Patients Treated Between 2000 and 2007 , 2010, Circulation. Cardiovascular interventions.

[19]  G. Biondi-Zoccai,et al.  A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions , 2009, Acta cardiologica.

[20]  W. Ghali,et al.  Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon? , 2008, International journal of cardiology.

[21]  R. Costa,et al.  Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry. , 2008, The Journal of invasive cardiology.

[22]  F. Eberli,et al.  Age‐Related Differences in the Use of Guideline‐Recommended Medical and Interventional Therapies for Acute Coronary Syndromes: A Cohort Study , 2008, Journal of the American Geriatrics Society.

[23]  Terry M Therneau,et al.  Coronary revascularization in the community. A population-based study, 1990 to 2004. , 2007, Journal of the American College of Cardiology.

[24]  M. Naylor,et al.  Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. , 2007, Circulation.

[25]  P. Serruys,et al.  Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.

[26]  I. Seong,et al.  Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery Disease , 2006, Circulation.

[27]  Harlan M. Krumholz,et al.  Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent Placement: Results From the PREMIER Registry , 2006, Circulation.

[28]  K. Alexander,et al.  Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. , 2005, Journal of the American College of Cardiology.

[29]  F. Fernández‐Avilés,et al.  Randomized Comparison of Sirolimus-Eluting Stent Versus Standard Stent for Percutaneous Coronary Revascularization in Diabetic Patients: The Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial , 2005, Circulation.

[30]  Jeffrey W Moses,et al.  Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. , 2003, The New England journal of medicine.

[31]  K. Anstrom,et al.  Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. , 2000, Journal of the American College of Cardiology.